Quantcast

Latest Excessive daytime sleepiness Stories

2014-07-03 12:26:04

Nonprofit Continues Support in the Search for Narcolepsy Cure WORCESTER, Mass., July 3, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy, Inc. (WUN), a nonprofit organization working to speed diagnosis of narcolepsy and help in the search for a cure, recently awarded a research grant for $50,000 to Dr. Emmanuel Mignot, Director of the Center for Sleep Sciences and the Center for Narcolepsy at Stanford University's School of Medicine....

2014-06-02 16:25:34

Study Demonstrated Robust Alerting Effect Consistent with Phase 2a Results DUBLIN, June 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a potential new treatment for the symptoms of excessive daytime sleepiness (EDS) in adults with narcolepsy. In the study, all primary and secondary endpoints were met and patients treated with JZP-110 experienced statistically significant...

2014-05-27 16:25:39

Phase 2b Data for JZP-110 in Adults with EDS in Narcolepsy Accepted as Late-Breaker Oral Presentation DUBLIN, May 27, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that new data for the investigational compound JZP-110 (previously ADX-N05) will be presented at the 28th Associated Professional Sleep Societies (APSS) Annual SLEEP Meeting, May 31 to June 4, 2014 in Minneapolis, Minn. The JZP-110 abstract was accepted as a late-breaker oral presentation. The...

2014-03-19 23:32:15

Eduardo Benarroch, M.D. of the Mayo Clinic in Rochester, MN. Has been awarded a research grant for his project "Mechanisms of Excessive Daytime Sleepiness and Sleep Related Respiratory Dysfunction in MSA.” In January 2014, The MSA Coalition announced the funding of five MSA research grants for a total of $219,000. Richester, MN (PRWEB) March 19, 2014 The Multiple System Atrophy Coalition has awarded a $50,000 grant to Dr. Eduardo Benarroch of the Mayo Clinic Rochester for a new...

2014-01-13 08:28:21

Terms include $125 million upfront payment in cash plus a potential of up to $272 million in milestone payments DUBLIN, Jan. 13, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Aerial BioPharma, LLC (Aerial) today announced that the companies have signed a definitive agreement under which Jazz Pharmaceuticals has acquired rights to ADX-N05, a novel compound in clinical development for the treatment of excessive daytime sleepiness in patients with narcolepsy. Under the...

2013-09-27 23:27:35

Historic FDA meeting on narcolepsy drug development brings narcolepsy community to FDA to offer candid and emotional remarks on how narcolepsy affects their lives, and on current treatment options. Silver Spring, MD (PRWEB) September 27, 2013 Narcolepsy Network, a national nonprofit organization supporting people with narcolepsy, joined dozens of others from the narcolepsy community at the FDA’s public meeting on narcolepsy drug development. The meeting was held on September 24 at FDA...

2013-05-17 23:01:17

Between May 17 and May 31, 2013, Dr. Avi Ishaaya will offer free screening and assessment for sleep apnea, an identifiable cause of hypertension. Los Angeles, CA (PRWEB) May 17, 2013 Dr. Avi Ishaaya, a nationally recognized sleep specialist and the founder of the I AM Sleep Program, specializing in portable home diagnosis and treatment of sleep apnea, will offer free sleep apnea assessments and $100 off the regular price of the home sleep test beginning May 17, World Hypertension Day, and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.